Yoon Choi
Yoon Choi
Yoon Choi
Yoon Choi

Biography

Yoon (Yoonyoung) Choi is an associate in the Mergers & Acquisitions and Private Equity Practice, based in Seoul.

Yoon advises Korean and global clients, including many of the largest Korean conglomerates and private equity firms, on cross-border M&A transactions, investments, strategic alliances and joint ventures.

Experience

  • A Middle East-based sovereign wealth fund on the US$150 million acquisition of newly issued convertible preferred shares of SK On Co., Ltd., a leading Korean battery maker.
  • KDB Investment-Hana Securities, Korea Investment Private Equity and KB Asset Management on the US$150 million acquisition of newly issued convertible preferred shares of US-based HyAxiom, Inc., a leading developer and manufacturer of hydrogen-based and other fuel cells and electrolyzer solutions.
  • A South Korean pharmaceutical company on its acquisition of various assets held by a UK-based pharmaceutical company in administration (and its subsidiaries, also in administration/joint receivership) engaged in the development of microbiome-based drugs.
  • Brite Energy Partners (BEP), a South Korean solar energy development and investment company, on its receipt of equity financing and further financing commitment, in an aggregate amount of more than US$230 million, from BlackRock Global Renewable Power Fund III, a unit of the world's largest asset manager BlackRock, Inc.
  • Korea Investment & Securities, a leading securities firm in Korea, on its formation of a leveraged lending joint venture, SF Credit Partners, with Stifel Financial Corp., an international full-service investment bank in the US.
  • KDB Investment, the private equity arm of Korea Development Bank, on its US$100 million investment in THINK Surgical, Inc., a California-based medical device company.
  • Lotte Corporation on its US$160 million pending acquisition of biologics assets in Syracuse, New York, from Bristol-Myers Squibb Company and its establishment of Lotte Biologics.
  • Green Cross, a Korean biopharmaceutical company, on its US$73 million acquisition of BioCentriq, Inc., a New Jersey-based biopharma company engaged in contract development & manufacturing organization business, from New Jersey Innovation Institute, Inc., a New Jersey non-profit corporation.
  • Hanmi Pharmaceutical on its acquisition of newly issued shares of Spectrum Pharmaceuticals, Inc., a US pharmaceutical company listed on Nasdaq.
  • LG Energy Solution on its acquisition of NEC Energy Solutions, a U.S. company engaged in the business of providing energy storage solutions, from NEC Corporation based in Japan.
District of Columbia
MA
(Law)
University of Bristol

Law School

BA
Korea University
English
Korean

Service areas